These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 15196814

  • 1. HIV hollow fiber SCID model for antiviral therapy comparison with SCID/hu model.
    Taggart BR, Harrington P, Hollingshead M.
    Antiviral Res; 2004 Jul; 63(1):1-6. PubMed ID: 15196814
    [Abstract] [Full Text] [Related]

  • 2. SCID-hu mice: a model for studying disseminated HIV infection.
    Goldstein H, Pettoello-Mantovani M, Katopodis NF, Kim A, Yurasov S, Kollmann TR.
    Semin Immunol; 1996 Aug; 8(4):223-31. PubMed ID: 8883145
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-4-transgenic hu-PBL-SCID mice: a model for the screening of antiviral drugs and immunotherapeutic agents against X4 HIV-1 viruses.
    Okuma K, Tanaka R, Ogura T, Ito M, Kumakura S, Yanaka M, Nishizawa M, Sugiura W, Yamamoto N, Tanaka Y.
    J Infect Dis; 2008 Jan 01; 197(1):134-41. PubMed ID: 18171296
    [Abstract] [Full Text] [Related]

  • 4. Gene therapy using a simian virus 40-derived vector inhibits the development of in vivo human immunodeficiency virus type 1 infection of severe combined immunodeficiency mice implanted with human fetal thymic and liver tissue.
    Goldstein H, Pettoello-Mantovani M, Anderson CM, Cordelier P, Pomerantz RJ, Strayer DS.
    J Infect Dis; 2002 May 15; 185(10):1425-30. PubMed ID: 11992277
    [Abstract] [Full Text] [Related]

  • 5. Validation of the SCID-hu Thy/Liv mouse model with four classes of licensed antiretrovirals.
    Stoddart CA, Bales CA, Bare JC, Chkhenkeli G, Galkina SA, Kinkade AN, Moreno ME, Rivera JM, Ronquillo RE, Sloan B, Black PL.
    PLoS One; 2007 Aug 01; 2(7):e655. PubMed ID: 17668043
    [Abstract] [Full Text] [Related]

  • 6. SCID-Hu mouse as a model for human lung HIV-1 infection.
    Cesbron JY, Agut H, Gosselin B, Candotti D, Raphaël M, Puech F, Grandadam M, Debré P, Capron A, Autran B.
    C R Acad Sci III; 1994 Jul 01; 317(7):669-74. PubMed ID: 7882151
    [Abstract] [Full Text] [Related]

  • 7. Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID mice.
    Lapenta C, Spada M, Santini SM, Racca S, Dorigatti F, Poli G, Belardelli F, Alfano M.
    Int Immunol; 2005 Apr 01; 17(4):469-75. PubMed ID: 15746245
    [Abstract] [Full Text] [Related]

  • 8. The SCID-hu mouse as a model for HIV-1 infection.
    Aldrovandi GM, Feuer G, Gao L, Jamieson B, Kristeva M, Chen IS, Zack JA.
    Nature; 1993 Jun 24; 363(6431):732-6. PubMed ID: 8515816
    [Abstract] [Full Text] [Related]

  • 9. Saquinavir-mediated inhibition of human immunodeficiency virus (HIV) infection in SCID mice implanted with human fetal thymus and liver tissue: an in vivo model for evaluating the effect of drug therapy on HIV infection in lymphoid tissues.
    Pettoello-Mantovani M, Kollmann TR, Raker C, Kim A, Yurasov S, Tudor R, Wiltshire H, Goldstein H.
    Antimicrob Agents Chemother; 1997 Sep 24; 41(9):1880-7. PubMed ID: 9303378
    [Abstract] [Full Text] [Related]

  • 10. The SCID-hu mouse: an in-vivo model for HIV-1 pathogenesis and stem cell gene therapy for AIDS.
    Jamieson BD, Aldrovandi GM, Zack JA.
    Semin Immunol; 1996 Aug 24; 8(4):215-21. PubMed ID: 8883144
    [Abstract] [Full Text] [Related]

  • 11. Development and applications of the SCID-hu mouse model.
    McCune JM.
    Semin Immunol; 1996 Aug 24; 8(4):187-96. PubMed ID: 8883141
    [Abstract] [Full Text] [Related]

  • 12. Chimeric toxins targeted to the human immunodeficiency virus type 1 envelope glycoprotein augment the in vivo activity of combination antiretroviral therapy in thy/liv-SCID-Hu mice.
    Goldstein H, Pettoello-Mantovani M, Bera TK, Pastan IH, Berger EA.
    J Infect Dis; 2000 Mar 24; 181(3):921-6. PubMed ID: 10720513
    [Abstract] [Full Text] [Related]

  • 13. Defining antibody protection against HIV-1 transmission in Hu-PBL-SCID mice.
    Koup RA, Safrit JT, Weir R, Gauduin MC.
    Semin Immunol; 1996 Aug 24; 8(4):263-8. PubMed ID: 8883150
    [Abstract] [Full Text] [Related]

  • 14. Development of a novel transgenic mouse/SCID-hu mouse system to characterize the in vivo behavior of reservoirs of human immunodeficiency virus type 1-infected cells.
    Wang EJ, Pettoello-Mantovani M, Anderson CM, Osiecki K, Moskowitz D, Goldstein H.
    J Infect Dis; 2002 Nov 15; 186(10):1412-21. PubMed ID: 12404156
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of antiretrovirals in animal models of HIV infection.
    Van Rompay KK.
    Antiviral Res; 2010 Jan 15; 85(1):159-75. PubMed ID: 19622373
    [Abstract] [Full Text] [Related]

  • 16. Development of a human thymic organ culture model for the study of HIV pathogenesis.
    Bonyhadi ML, Su L, Auten J, McCune JM, Kaneshima H.
    AIDS Res Hum Retroviruses; 1995 Sep 15; 11(9):1073-80. PubMed ID: 8554904
    [Abstract] [Full Text] [Related]

  • 17. thy/liv-SCID-hu mice: a system for investigating the in vivo effects of multidrug therapy on plasma viremia and human immunodeficiency virus replication in lymphoid tissues.
    Pettoello-Mantovani M, Kollmann TR, Katopodis NF, Raker C, Kim A, Yurasov S, Wiltshire H, Goldstein H.
    J Infect Dis; 1998 Feb 15; 177(2):337-46. PubMed ID: 9466519
    [Abstract] [Full Text] [Related]

  • 18. Potent anti-R5 human immunodeficiency virus type 1 effects of a CCR5 antagonist, AK602/ONO4128/GW873140, in a novel human peripheral blood mononuclear cell nonobese diabetic-SCID, interleukin-2 receptor gamma-chain-knocked-out AIDS mouse model.
    Nakata H, Maeda K, Miyakawa T, Shibayama S, Matsuo M, Takaoka Y, Ito M, Koyanagi Y, Mitsuya H.
    J Virol; 2005 Feb 15; 79(4):2087-96. PubMed ID: 15681411
    [Abstract] [Full Text] [Related]

  • 19. Use of standardized SCID-hu Thy/Liv mouse model for preclinical efficacy testing of anti-human immunodeficiency virus type 1 compounds.
    Rabin L, Hincenbergs M, Moreno MB, Warren S, Linquist V, Datema R, Charpiot B, Seifert J, Kaneshima H, McCune JM.
    Antimicrob Agents Chemother; 1996 Mar 15; 40(3):755-62. PubMed ID: 8851606
    [Abstract] [Full Text] [Related]

  • 20. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.
    Ambrose Z, Boltz V, Palmer S, Coffin JM, Hughes SH, Kewalramani VN.
    J Virol; 2004 Dec 15; 78(24):13553-61. PubMed ID: 15564466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.